(Q40932806)

25 September 2017

1 reference

title

A review on the strategies for the development and application of new anti-arthritic agents (English)

1 reference

25 September 2017

A J Lewis

1

1 reference

25 September 2017

A F Keft

series ordinal

2

1 reference

25 September 2017

publication date

1 November 1995

1 reference

Immunopharmacology and Immunotoxicology

25 September 2017

published in

1 reference

25 September 2017

volume

17

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

607-663

1 reference

Rheumatoid arthritis. Pathophysiology and implications for therapy

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Clinical management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Eicosanoids and rheumatology: inflammatory and vascular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Eicosanoids and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Mediators of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Eicosanoids, thermogenesis and thermoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Nonsteroidal antiinflammatory drugs--differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The mechanisms of action of nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

A new view of prostaglandin E regulation of the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Characterization of the promoter of human prostaglandin H synthase-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Cyclooxygenase-independent effects of non-steroidal anti-inflammatory drugs on the neutrophil respiratory burst

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Development of selective tight-binding inhibitors of leukotriene A4 hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Phospholipase A2 enzymes: regulation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Possible role of mammalian secretory group II phospholipase A2 in T-lymphocyte activation: implication in propagation of inflammatory reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Design and synthesis of some substrate analogue inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Conformational changes in phospholipase A2 upon binding to micellar interfaces in the absence and presence of competitive inhibitors. A 1H and 15N NMR study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Fatty acid amides: scooting mode-based discovery of tight-binding competitive inhibitors of secreted phospholipases A2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Phospholipase A2 Inhibitors from Marine Organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Glucocorticoids and prostaglandin synthesis: we cannot see the wood for the trees

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Glucocorticoids, lipocortins and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Phospholipase A2 inhibition by alkylbenzoylacrylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The matrix metalloproteinases and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Human cartilage proteoglycans as T cell autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Collagenase in synovitis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Purification and characterization of the human stromelysin catalytic domain expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Substrate specificity of the human matrix metalloproteinase stromelysin and the development of continuous fluorometric assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Inhibition of collagenase by aranciamycin and aranciamycin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Strategies for the development of new antiarthritic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Proteinase-mediated cartilage degradation in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Cell adhesion/signalling: biology and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Prevention of Activated Neutrophil Adhesion to Endothelium by Soluble Adhesion Protein GMP140

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Inhibition of intercellular adhesion molecule 1-dependent biological activities by a synthetic peptide analog

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

High affinity binding of the leucocyte adhesion molecule L-selectin to 3'-sulphated-Le(a) and -Le(x) oligosaccharides and the predominance of sulphate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Novel sulfated ligands for the cell adhesion molecule E-selectin revealed by the neoglycolipid technology among O-linked oligosaccharides on an ovarian cystadenoma glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Sulfated glycolipids are ligands for a lymphocyte homing receptor, L-selectin (LECAM-1), Binding epitope in sulfated sugar chain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Identification of an E-selectin region critical for carbohydrate recognition and cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Enhanced interaction of L-selectin with the high endothelial venule ligand via selectively oxidized sialic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Therapeutic applications of oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Inhibition of leucocyte adhesion molecule upregulation by tumor necrosis factor alpha: a novel mechanism of action of sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The vascular E-selectin binds to the leukocyte integrins CD11/CD18.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Cytokines and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

How important are T cells in chronic rheumatoid synovitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Anticytokine strategies in the treatment of the systemic inflammatory response syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Identification of a monocyte specific pre-interleukin 1 beta convertase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The role of cytokines and their inhibitors in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Sulfasalazine inhibits the binding of TNF alpha to its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Neuropeptide α-MSH antagonizes IL-6- and TNF-induced fever

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Differential regulation of TNF-alpha and IL-1beta production from endotoxin stimulated human monocytes by phosphodiesterase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

In situ hybridization of IL-6 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Inhibition of T cell activation by MHC blockade: a possible strategy for immunointervention in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Cyclosporine and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

FK 506 and autoimmune disease: perspective and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Tumor necrosis factor in the serum of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Tenidap: a novel inhibitor of calcium influx in a mast cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

The effect of second-line antirheumatic drugs on interleukin-8 mRNA synthesis and protein secretion in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923979509037187

10.3109/08923979509037187

21 January 2018

Identifiers

DOI

1 reference

release_dkmhtsvei5ecbpzvkekqeeoywa

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dkmhtsvei5ecbpzvkekqeeoywa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference